Naviswiss receives FDA clearance for hip navigation technology

The FDA gave Naviswiss FDA clearance for its navigation technology for hip replacement surgery, allowing the company to begin selling its products in all U.S. markets.

Advertisement

The clearance is for both primary replacement and revision hip replacement surgery. The technology works with several surgical approaches and available implants on the market.

Naviswiss now offers its products in the U.S., Europe, Australia and Asia.

More articles on surgery centers:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.